Amicus Therapeutics Inc (FOLD)
10.42
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
10.42
0.00 (0.00%)
After-Hours: 16:55
Amicus Therapeutics Max Drawdown (5Y): 74.97% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 74.97% |
| March 31, 2024 | 74.97% |
| February 29, 2024 | 74.97% |
| January 31, 2024 | 74.97% |
| December 31, 2023 | 74.97% |
| November 30, 2023 | 74.97% |
| October 31, 2023 | 74.97% |
| September 30, 2023 | 74.97% |
| August 31, 2023 | 74.97% |
| July 31, 2023 | 74.97% |
| June 30, 2023 | 74.97% |
| May 31, 2023 | 74.97% |
| April 30, 2023 | 74.97% |
| March 31, 2023 | 74.97% |
| February 28, 2023 | 74.97% |
| January 31, 2023 | 74.97% |
| December 31, 2022 | 74.97% |
| November 30, 2022 | 74.97% |
| October 31, 2022 | 74.97% |
| September 30, 2022 | 74.97% |
| August 31, 2022 | 74.97% |
| July 31, 2022 | 74.97% |
| June 30, 2022 | 74.97% |
| May 31, 2022 | 74.97% |
| April 30, 2022 | 71.55% |
| Date | Value |
|---|---|
| March 31, 2022 | 68.30% |
| February 28, 2022 | 67.30% |
| January 31, 2022 | 65.05% |
| December 31, 2021 | 65.01% |
| November 30, 2021 | 69.28% |
| October 31, 2021 | 71.86% |
| September 30, 2021 | 75.15% |
| August 31, 2021 | 75.15% |
| July 31, 2021 | 75.15% |
| June 30, 2021 | 75.15% |
| May 31, 2021 | 75.15% |
| April 30, 2021 | 75.15% |
| March 31, 2021 | 75.15% |
| February 28, 2021 | 75.15% |
| January 31, 2021 | 75.15% |
| December 31, 2020 | 75.15% |
| November 30, 2020 | 75.15% |
| October 31, 2020 | 75.15% |
| September 30, 2020 | 75.15% |
| August 31, 2020 | 75.15% |
| July 31, 2020 | 75.15% |
| June 30, 2020 | 75.15% |
| May 31, 2020 | 75.15% |
| April 30, 2020 | 75.15% |
| March 31, 2020 | 75.15% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
65.01%
Minimum
Dec 2021
75.15%
Maximum
May 2019
74.28%
Average
74.97%
Median
May 2022
Max Drawdown (5Y) Benchmarks
| TG Therapeutics Inc | 93.19% |
| Geron Corp | 86.09% |
| Vanda Pharmaceuticals Inc | 89.11% |
| Fate Therapeutics Inc | 98.59% |
| Editas Medicine Inc | 94.25% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -16.54 |
| Beta (5Y) | 0.7963 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 53.00% |
| Historical Sharpe Ratio (5Y) | -0.1447 |
| Historical Sortino (5Y) | -0.2446 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.11% |